Energy price swings linked to Iran have kept inflation expectations and central bank policy in the spotlight, which has made reliable income harder to find. That is why Dividend Powerhouses with 3%+ yields and solid coverage can feel so appealing right now. This article walks through three stocks from the Dividend Powerhouses screener that stand out for income focused investors seeking consistency.

The three Dividend Powerhouses highlighted below are just a sample, and the full screen surfaced 87 more companies with income profiles and stories that are just as compelling but not covered here. To go deeper on this idea, head straight to the Dividend Powerhouses (3%+ Yield) screener to analyze yields, identify coverage strength, and focus on the highest conviction dividend opportunities.

Accenture (ACN)

Overview: Accenture is a Dublin based consulting and technology services company that helps large businesses and governments modernize their operations through cloud, data, AI, cybersecurity, and managed services. It designs and runs both the software and hardware that sit behind everything from banking systems to supply chains and customer experiences worldwide.

Operations: Accenture generates most of its revenue from its Products segment at about US$22.3b, followed by Health & Public Service at about US$14.9b, Financial Services at about US$13.8b, Communications, Media & Technology at about US$12.4b, and Resources at about US$9.8b.

Market Cap: US$109.2b

Income focused investors may want Accenture on their radar because it couples a 3.69% dividend yield with high quality earnings and strong profitability, including a current ROE of 23.7% and forecast ROE of 24.2%. The stock trades on a P/E of 13.9x, below both the US market and US IT sector averages. This comes at a time when the company is rolling out AI led offerings and a US$9b acquisition program aimed at higher growth areas such as operational technology security and mid market clients. The flip side is real, with recent earnings pressure, softer bookings and the risk that AI reduces demand for traditional consulting work. This is why sentiment has been cautious and why a closer look can be so interesting.

Accenture’s valuation and income profile appear out of sync with its AI push and US$9b acquisition program. To see what the market might be missing, scan the analysis report for Accenture and identify the twist in the story.

Build your own Accenture style dividend shortlist

Accenture and the two other stocks in this article all came from a single Simply Wall St screener, which is where the real opportunity starts for you. Use our flexible Screener to mix filters across valuation, dividends, quality and risks, or jump straight into our curated Investing Ideas for ready made starting points.

Medtronic (MDT)

Overview: Medtronic is a global medical device company headquartered in Ireland that supplies hospitals and clinicians with a wide range of products, from heart pacemakers and cardiac ablation systems to spine and brain implants, surgical tools, and diabetes management devices. Its technology is used across cardiovascular care, neurology, and surgical procedures, often supporting long term treatment of chronic diseases.

Operations: Medtronic generates most of its US$36.4b revenue from Cardiovascular at about US$14.0b, followed by Neuroscience at about US$10.3b, Medical Surgical at about US$8.8b, and Other at about US$3.2b, with sales split roughly evenly between the United States and the rest of the world.

Market Cap: US$115.9b

Medtronic earns attention in a dividend focused shortlist because it pairs a 3.11% yield and a 49 year record of annual dividend increases with exposure to long running trends in chronic disease and digital health. The product pipeline in cardiac ablation, surgical robotics and AI supported surgery shows recent traction, helped by CE marks, FDA designations and targeted acquisitions. At the same time, some segments such as U.S. Diabetes and parts of MedSurg face headwinds, and recent recalls highlight the regulatory risk that comes with complex devices. Earnings growth has been modest so far and margins have eased, yet analysts still see scope for profit improvement as restructuring and the Diabetes separation progress. The key question is whether that mix of steady income and gradual change in the portfolio is fully reflected in today’s price.

Medtronic’s slow and steady dividend story might be hiding more than it shows. See how the product pipeline, portfolio reshuffle, and regulation risk fit together inside the analysis report for Medtronic.

VICI Properties (VICI)

Overview: VICI Properties is a New York based real estate investment trust that owns and leases a large portfolio of gaming, hospitality, and other experiential properties, including Caesars Palace, MGM Grand, and the Venetian on the Las Vegas Strip. It collects rent from leading operators under long term, triple net leases, which means tenants cover most property level costs while VICI focuses on owning and financing the real estate.

Operations: VICI Properties generates all of its US$4.1b in revenue from real estate investment activities, almost entirely in the United States.

Market Cap: US$29b

Income investors looking at VICI Properties get a REIT with large scale Las Vegas icons and a growing mix of theme parks, resorts, and youth sports facilities, all tied to long term inflation linked leases. Recent deals in Caribbean resorts, Canadian gaming assets, and new tenants such as Golden Entertainment and Club Med show how the portfolio is widening beyond a handful of casino operators, even as tenant concentration and debt funded growth keep risk firmly on the table. Earnings growth has slowed recently and return on equity sits in single digits. The key consideration for investors is how resilient that rent stream remains if online gaming, funding costs, or key tenants start to have a material impact on the business.

VICI Properties’ inflation linked rent and triple net leases may be masking a much bigger story. Trace how tenant concentration, debt and diversification efforts really stack up inside the analysis report for VICI Properties

Seeking Alternatives Before The Crowd Moves

Fresh ideas do not stay under the radar for long. Some stocks are already building breakout momentum while others risk getting caught dropping later. Check these before the crowd and consider your options.

• Target resilient compounding potential by reviewing the curated 83 resilient stocks with low risk scores that aim to keep portfolio volatility contained while fundamentals still matter.
• Explore the AI infrastructure build out by scanning the hand picked 55 AI infrastructure stocks before broader attention and pricing pressure emerge.
• Review opportunities in a potential energy build cycle by assessing the focused 91 nuclear energy infrastructure stocks while sentiment is still forming and pricing remains fluid.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.